HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?

AbstractBACKGROUND:
The combination of bicarbonate and mannitol (BIC/MAN) is commonly used to prevent renal failure (RF) in patients with rhabdomyolysis despite the absence of sufficient evidence validating its use. The purpose of this study was to determine whether BIC/ MAN is effective in preventing RF in patients with rhabdomyolysis caused by trauma.
METHODS:
This study was a review of all adult trauma intensive care unit (ICU) admissions over 5 years (January 1997-September 2002). Creatine kinase (CK) levels were checked daily (abnormal,>520 U/L). RF was defined as a creatinine greater than 2.0 mg/dL. Patients received BIC/MAN on the basis of the surgeon's discretion.
RESULTS:
Among 2,083 trauma ICU admissions, 85% had abnormal CK levels. Overall, RF occurred in 10% of trauma ICU patients. A CK level of 5,000 U/L was the lowest abnormal level associated with RF; 74 of 382 (19%) patients with CK greater than 5,000 U/L developed RF as compared with 143 of 1,701 (8%) patients with CK less than 5,000 U/L (p < 0.0001). Among patients with CK greater than 5,000 U/L, there was no difference in the rates of RF, dialysis, or mortality between those who received BIC/MAN and those who did not. Subanalysis of groups with various levels of CK still failed to show any benefit of BIC/MAN.
CONCLUSION:
Abnormal CK levels are common among critically injured patients, and a CK level greater than 5,000 U/L is associated with RF. BIC/MAN does not prevent RF, dialysis, or mortality in patients with creatine kinase levels greater than 5,000 U/L. The standard of administering BIC/MAN to patients with post-traumatic rhabdomyolysis should be reevaluated.
AuthorsCarlos V R Brown, Peter Rhee, Linda Chan, Kelly Evans, Demetrios Demetriades, George C Velmahos
JournalThe Journal of trauma (J Trauma) Vol. 56 Issue 6 Pg. 1191-6 (Jun 2004) ISSN: 0022-5282 [Print] United States
PMID15211124 (Publication Type: Journal Article)
Chemical References
  • Diuretics, Osmotic
  • Mannitol
  • Sodium Bicarbonate
  • Creatine Kinase
Topics
  • Acute Kidney Injury (blood, etiology, prevention & control)
  • Creatine Kinase (blood)
  • Diuretics, Osmotic (administration & dosage, therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Logistic Models
  • Male
  • Mannitol (administration & dosage, therapeutic use)
  • Middle Aged
  • Odds Ratio
  • Rhabdomyolysis (blood, complications)
  • Risk Factors
  • Sodium Bicarbonate (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: